Cost-Effectiveness of Varicella Vaccination for children aged 1–4 in Shanghai

Home > Cost-Effectiveness of Varicella Vaccination for children aged 1–4 in Shanghai

China has not yet incorporated varicella (chickenpox) vaccination into its National Immunization Program (NIP), resulting in diverse regional vaccination approaches. A publication in the American Journal of Preventative Medicine examined five different immunization scenarios in Shanghai to identify the most effective varicella vaccination strategy, considering both cost-effectiveness and projected costs over a five-year period. The study found that one dose of routine varicella vaccination was the most cost-saving  and cost-effective (dominant) scenario. Two doses of the vaccination had the highest QALY and its ICER was below the willingness-to-pay threshold. The authors concluded that a two-dose varicella vaccination strategy targeting 1- and 4-year-old children, with a 95% coverage rate, was the most optimal strategy in Shanghai.

  • Primary authorBaichu Guan, Fudan University
  • LanguageEnglish

Submit your work

Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.